Eledon Pharmaceuticals (ELDN) vs Emmis Acquisition (EMIS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Eledon Pharmaceuticals (ELDN) has outperformed Emmis Acquisition (EMIS) over the past year, gaining 23.6% versus a gain of 4.4%. Emmis Acquisition is the larger company by market cap ($163.4 million vs $150.3 million), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ELDN | EMIS |
|---|---|---|
| Share price | $1.78 | $10.36 |
| Market cap | $150.34M | $163.36M |
| 1-day change | -6.32% | +0.15% |
| YTD return | +17.88% | +4.07% |
| 1-year return | +23.61% | +4.39% |
| 5-year return | -65.64% | — |
| EPS (TTM) | $-0.73 | — |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| Net income (latest FY) | $-45.62M | — |
| 52-week high | $4.49 | $10.38 |
| 52-week low | $1.39 | $9.92 |
| Distance from 52-week high | -60.36% | -0.24% |
| Analyst consensus | strong_buy | — |
| Avg. price target upside | +405.62% | — |
| Average volume | 931.77K | 16.19K |
| Shares outstanding | 84.46M | 11.94M |
| Employees | 33 | — |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- ELDN has outperformed EMIS by 19.2 percentage points over the past year.
About Eledon Pharmaceuticals
ELDN stock →Eledon Pharmaceuticals, Inc. operates as a clinical stage biotechnology company.
Health Care · Biotechnology: Pharmaceutical Preparations · 33 employees
About Emmis Acquisition
EMIS stock →Emmis Acquisition Corp. focuses on effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Health Care · Biotechnology: Pharmaceutical Preparations
ELDN vs EMIS FAQ
Which is bigger, Eledon Pharmaceuticals or Emmis Acquisition?
Emmis Acquisition (EMIS) is larger, with a market capitalization of $163.36M compared with $150.34M for Eledon Pharmaceuticals (ELDN).
Which stock has performed better over the past year, ELDN or EMIS?
ELDN returned +23.61% over the past 12 months, compared with +4.39% for EMIS (price return, excluding dividends). Past performance does not predict future results.
Are Eledon Pharmaceuticals and Emmis Acquisition in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.